Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kyntra Bio
Age
21–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Written informed consent
Body mass index not exceeding 32.0 kg/m2
If female, subject must meet one of the following criteria: a) surgically sterile (hysterectomy or bilateral tubal ligation) OR b) at least two years postmenopausal OR c) using a dual method of contraception and have a negative serum pregnancy test if of childbearing potential
Diagnosis of type 1 or type 2 diabetes according to the American Diabetes Association
Fasting plasma glucose of ≥ 126 mg/dL or current treatment with oral hypoglycemic agents or insulin
Microalbuminuria defined as albumin to creatinine ratio in a spot collection (first void) of 30 - 300 mg/gram confirmed by two samples two to three days apart
Serum creatinine of no more than 1.5 mg/dL for men and no more than 1.1 mg/dL for women
You may not be if
Female subjects who are pregnant or lactating
Non-diabetic renal disease
History of allergic or anaphylactic reaction to human, humanized, chimeric, or murine monoclonal antibodies
Coronary artery bypass graft surgery, myocardial infarction, cerebrovascular accident, percutaneous transluminal angioplasty, transient ischemic attack, history of unstable angina, known heart failure, uncontrolled cardiac arrhythmia, or uncontrolled hypertension within six months prior to Day 0
Bilirubin, aspartate aminotransferase (AST), or alanine aminotransferase (ALT) \> 1.5 times the upper limit of normal
History of cancer of any type in the past 5 years, except non- melanomatous skin cancer, localized bladder cancer, or in situ cervical cancer.
Clinically significant and uncontrolled medical condition considered a high risk for participation in an investigational study
Trauma or surgical procedures (including dental) within six months prior to Day 0
Planned elective surgery during the study and for 3 months following the end of the study
Participation in studies of investigational drugs within 6 weeks prior to first dose